Austin Health

Title
Ipilimumab versus ipilimumab plus anti-PD-1 for metastatic melanoma - Authors' reply.
Publication Date
2021-08
Author(s)
da Silva, Ines Pires
Ahmed, Tasnia
Reijers, Irene L M
Warner, Allison Betof
Patrinely, James Randall
Serra-Bellver, Patricio
Allayous, Clara
Mangana, Joanna
Zimmer, Lisa
Trojaniello, Claudia
Klein, Oliver
Gerard, Camille L
Michielin, Olivier
Haydon, Andrew
Ascierto, Paolo A
Carlino, Matteo S
Lebbe, Celeste
Lorigan, Paul
Johnson, Douglas B
Sandhu, Shahneen
Lo, Serigne N
Menzies, Alexander M
Long, Georgina V
Type of document
Journal Article
DOI
10.1016/S1470-2045(21)00419-8
Link
link
Citation
The Lancet. Oncology 2021; 22(8): e343-e344
Jornal Title
The Lancet. Oncology

Files:

NameSizeformatDescriptionLink